Gene · 722
Papers2,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic analysis of plasma exosomes in patients with non-small cell lung cancer. | Transl Lung Cancer Res | 2022 | 35958340 | PubTator, text mining | PubMed |
| B serum proteome profiles revealed dysregulated proteins and mechanisms associated with insomnia patients: A preliminary study. | Front Integr Neurosci | 2022 | 35958162 | PubTator, text mining | PubMed |
| diaPASEF Proteomics and Feature Selection for the Description of Sputum Proteome Profiles in a Cohort of Different Subtypes of Lung Cancer Patients and Controls. | Int J Mol Sci | 2022 | 35955870 | PubTator, text mining | PubMed |
| Integration of protein context improves protein-based COVID-19 patient stratification. | Clin Proteomics | 2022 | 35953823 | PubTator, text mining | PubMed |
| Tear proteomics analysis of patient suffered from delayed mustard gas keratopathy. | Proteome Sci | 2022 | 35948930 | PubTator, text mining | PubMed |
| Asymmetric depth-filtration: A versatile and scalable method for high-yield isolation of extracellular vesicles with low contamination. | J Extracell Vesicles | 2022 | 35942823 | PubTator, text mining | PubMed |
| PTX3 structure determination using a hybrid cryoelectron microscopy and AlphaFold approach offers insights into ligand binding and complement activation. | Proc Natl Acad Sci U S A | 2022 | 35939690 | PubTator, text mining | PubMed |
| A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing. | Front Pharmacol | 2022 | 35935840 | PubTator, text mining | PubMed |
| Association Between Plasma Exosomes S100A9/C4BPA and Latent Tuberculosis Infection Treatment: Proteomic Analysis Based on a Randomized Controlled Study. | Front Microbiol | 2022 | 35935235 | PubTator, text mining | PubMed |
| Early Prediction of COVID-19 Patient Survival by Targeted Plasma Multi-Omics and Machine Learning. | Mol Cell Proteomics | 2022 | 35931319 | PubTator, text mining | PubMed |
| Genome-wide association study of SARS-CoV-2 infection in Chinese population. | Eur J Clin Microbiol Infect Dis | 2022 | 35927536 | PubTator, text mining | PubMed |
| Multi-Data Integration Towards a Global Understanding of the Neurological Impact of Human Brain Severe Acute Respiratory Syndrome Coronavirus 2 Infection. | Front Integr Neurosci | 2022 | 35910337 | PubTator, text mining | PubMed |
| A Genome-Wide Search for Candidate Genes of Meat Production in Jalgin Merino Considering Known Productivity Genes. | Genes (Basel) | 2022 | 35893074 | PubTator, text mining | PubMed |
| Current Advances in the Development of Hydrogel-Based Wound Dressings for Diabetic Foot Ulcer Treatment. | Polymers (Basel) | 2022 | 35890541 | PubTator, text mining | PubMed |
| Tumor-Stroma Ratio and Programmed Cell Death Ligand 1 Expression in Preoperative Biopsy and Matched Laryngeal Carcinoma Surgical Specimen. | Int J Mol Sci | 2022 | 35887397 | PubTator, text mining | PubMed |
| Pathogenic Variants in Cardiomyopathy Disorder Genes Underlie Pediatric Myocarditis-Further Impact of Heterozygous Immune Disorder Gene Variants? | J Cardiovasc Dev Dis | 2022 | 35877578 | PubTator, text mining | PubMed |
| Efficacy of Platelet-Rich Plasma Injection in the Management of Rotator Cuff Tendinopathy: A Review of the Current Literature. | Cureus | 2022 | 35875287 | PubTator, text mining | PubMed |
| Dengue Infection - Recent Advances in Disease Pathogenesis in the Era of COVID-19. | Front Immunol | 2022 | 35874775 | PubTator, text mining | PubMed |
| Exploring the function of factor XIII free B subunit: Interactions with complement factors and a novel approach to identify potential binding partners. | Res Pract Thromb Haemost | 2022 | 35873217 | PubTator, text mining | PubMed |
| The Effects of Poria cocos on Rho Signaling-Induced Regulation of Mobility and F-Actin Aggregation in MK-801-Treated B35 and C6 Cells. | Behav Neurol | 2022 | 35864844 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/722/papers?page=28